Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011551 (
depersonalization
)
1,117
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Schizotypal and borderline personality disorders (
SPD
and BPD, respectively) appear to be different at follow-up, yet they are poorly discriminated from each other by current DSM-III symptom criteria. In the Chestnut Lodge Follow-up Study, three axis II study cohorts (pure
SPD
, n = 10; pure BPD, n = 81; mixed
SPD
/BPD, n = 18) with distinctive outcomes are defined using current borderline systems. This study compares the relative frequency with which individual symptom criteria from each system discriminate across study cohorts. Findings suggest that for
SPD
, the most characteristic (core) DSM-III symptoms are odd communication, suspiciousness/paranoid ideation, and social isolation, while the least discriminating symptom is illusions/
depersonalization
/derealization; the core DSM-III symptoms for BPD are unstable relationships, impulsivity, and self-damaging acts, while the least discriminating symptoms are inappropriate anger and intolerance of aloneness; depression as a symptom does not discriminate between
SPD
and BPD; and transient psychoses and brief paranoid experiences and/or regression in treatment discriminate for
SPD
but against BPD and therefore fit better as
SPD
criteria. Results support the retention of some, but the elimination of other, DSM-III symptom criteria for the diagnosis of
SPD
and BPD.
...
PMID:Testing DSM-III symptom criteria for schizotypal and borderline personality disorders. 381 9